144 related articles for article (PubMed ID: 37905665)
1. Whole-breast Radiotherapy With Boost for Node-negative Breast Cancer: Conventional
Rades D; Eggert MC; Janssen S; Yu NY
In Vivo; 2023; 37(6):2628-2633. PubMed ID: 37905665
[TBL] [Abstract][Full Text] [Related]
2. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
[TBL] [Abstract][Full Text] [Related]
3. Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up.
Yoshida-Ichikawa Y; Horimoto Y; Shikama N; Yanagisawa N; Koyanagi A; Arakawa A; Saito M; Karasawa K
Breast Cancer; 2021 Jan; 28(1):92-98. PubMed ID: 32719997
[TBL] [Abstract][Full Text] [Related]
4. Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.
Kawaguchi H; Tsujino K; Miki M; Matsumoto Y; Ota Y; Hirokaga K; Takao S; Soejima T; Sasaki R
Jpn J Clin Oncol; 2019 Jun; 49(6):545-553. PubMed ID: 30796835
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
6. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost.
Chan EK; Tabarsi N; Tyldesley S; Khan M; Woods R; Speers C; Weir L
Am J Clin Oncol; 2016 Oct; 39(5):473-8. PubMed ID: 24824143
[TBL] [Abstract][Full Text] [Related]
8. Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Chua BH; Link EK; Kunkler IH; Whelan TJ; Westenberg AH; Gruber G; Bryant G; Ahern V; Purohit K; Graham PH; Akra M; McArdle O; O'Brien P; Harvey JA; Kirkove C; Maduro JH; Campbell ID; Delaney GP; Martin JD; Vu TTT; Muanza TM; Neal A; Olivotto IA;
Lancet; 2022 Aug; 400(10350):431-440. PubMed ID: 35934006
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
[No Abstract] [Full Text] [Related]
10. Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients.
Karasawa K; Kunogi H; Hirai T; Hojo H; Hirowatari H; Izawa H; Ito K; Sasai K; Kawashima M; Furuya T; Sugimoto S; Kurokawa C; Ozawa S; Saito M
Breast Cancer; 2014 Jul; 21(4):402-8. PubMed ID: 22968629
[TBL] [Abstract][Full Text] [Related]
11. Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation.
Rock K; Ng S; Murray L; Su J; Fyles A; Koch CA
Breast; 2018 Oct; 41():89-92. PubMed ID: 30015257
[TBL] [Abstract][Full Text] [Related]
12. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
Smith BD; Bentzen SM; Correa CR; Hahn CA; Hardenbergh PH; Ibbott GS; McCormick B; McQueen JR; Pierce LJ; Powell SN; Recht A; Taghian AG; Vicini FA; White JR; Haffty BG
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):59-68. PubMed ID: 20638191
[TBL] [Abstract][Full Text] [Related]
13. Comparison between the use of hypofractionated and conventionally fractionated radiotherapy in early breast cancer: A single-center real-world study in Taiwan.
Chuang WK; Cheng SH; Hung CF; Huang TT; Jen CW; Yen JH; Tsai YC
J Formos Med Assoc; 2022 Aug; 121(8):1588-1595. PubMed ID: 35094914
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated whole breast irradiation in association with hypofractionated or normofractionated boost to the tumor bed in early breast cancer: tolerance and efficacy analysis.
Oses G; Barreto TD; Cases C; Muñoz-Guglielmetti D; Antelo G; Mollà M
Clin Transl Oncol; 2023 Aug; 25(8):2419-2426. PubMed ID: 36947361
[TBL] [Abstract][Full Text] [Related]
15. Significance of Hypofractionated Radiotherapy in Postoperative Irradiation for Breast Cancer: An Asian Multi-institutional Prospective Study.
Okonogi N; Kono S; Karasawa K; Banu PA; Xu X; Erawati D; Adylkhanov T; Jang WI; E Y; Calaguas MJ; Thephamongkhol K; Dung TA; Ng WNP; Kato S;
Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):463-471. PubMed ID: 37179216
[TBL] [Abstract][Full Text] [Related]
16. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
17. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
[TBL] [Abstract][Full Text] [Related]
18. Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.
Schmeel LC; Koch D; Schmeel FC; Röhner F; Schoroth F; Bücheler BM; Mahlmann B; Leitzen C; Schüller H; Tschirner S; Fuhrmann A; Heimann M; Brüser D; Abramian AV; Müdder T; Garbe S; Vornholt S; Schild HH; Baumert BG; Wilhelm-Buchstab TM
Radiother Oncol; 2020 May; 146():172-179. PubMed ID: 32171945
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant hypofractionated versus conventional whole breast radiation therapy for early-stage breast cancer: long-term hospital-related morbidity from cardiac causes.
Chan EK; Woods R; McBride ML; Virani S; Nichol A; Speers C; Wai ES; Tyldesley S
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):786-92. PubMed ID: 24606848
[TBL] [Abstract][Full Text] [Related]
20. A single-institution retrospective analysis of intraoperative radiation boost during breast-conservation treatment for breast cancer.
Hochhertz F; Hass P; Röllich B; Ochel HJ; Gawish A
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5743-5749. PubMed ID: 36566484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
